Cathay Biotech: Announcement on the Company\'s Controlling Shareholder\'s Proposal to Repurchase Shares
Cathay Biotech Inc.: Shanghai Cathay Biotech Inc. issued a revised risk warning and mitigation measures for the dilution of immediate returns for the issuance of A shares to specific parties in 2023.
Shanghai Cathay Biotech Inc. issued a revised risk warning and mitigation measures for the dilution of immediate returns for the issuance of A shares to specific parties in 2023.
Legal opinion on the 2023 annual general meeting of shareholders.
Announcement of Resolutions of the Shareholders' Meeting for the Fiscal Year 2023
Materials for the 2023 Annual Shareholders Meeting.
Notice on the convening of the 2023 annual shareholder meeting.
2023 Internal Control Evaluation Report
2023 Board Audit Committee Performance Report
Special report of the board of directors on the 2023 independence self-inspection of independent directors
Report on the performance of supervisory duties by the Board of Auditors on accounting firms
2024 Action Plan to Improve Quality, Increase Efficiency, and Value Rewards
Announcement on the postponement of some fund-raising projects
Announcement of Resolutions of the Fourth Extraordinary General Meeting of Shareholders in 2023
Legal Opinion of the Fourth Extraordinary General Meeting of Shareholders in 2023
Materials of the 2023 Fourth Extraordinary General Meeting of Shareholders
Notice on amending the “Articles of Association” and part of the management system and processing of industrial and commercial change registration
Articles of Association (revised in December 2023)
Rules of procedure for board meetings (revised in December 2023)
Notice on holding the fourth Extraordinary General Meeting of Shareholders in 2023
No Data
No Data